Corporate calendar for Aldeyra The (ALDX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-0.06 | $79M |
| 2026-09-14 | ||
| 2026-09-14 | $144M | |
| 2026-09-14 | $563M | |
| 2026-09-14 | $-0.05 | $3M |
| 2026-09-14 | $0.06 | $3M |
Price
| Price | $1.37 |
| Market Cap | $83M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 18 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 19 |
| Avg rating (1-5) | 0.95 |
Related companies: ACIU · AMRN · ANRO · CADL · CLLS · CTNM · GNLX
Explore sector: Healthcare · Biotechnology
More sections of ALDX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks